Has Anthony Berg, MD received payments from drug or device companies?

Yes. Drug and device makers reported $164,980 in general payments to Anthony Berg, MD across 527 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anthony Berg, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anthony Berg, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anthony Berg, MD

Pain Medicine · Rockwall, TXNPI 1811104664

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $102,219 of the $164,980 with a category attached, or 62.0%. Boston Scientific accounts for 75.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $57,683 and has fallen 74.1% since, to $14,943 in 2025. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$164,980in general payments, 2019–2025

Across 527 payments — averaging $313.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$124K
Medtronic$18K
Neuroone Medical Technologies Corporation$18K
Saluda Medical Americas, Inc.$1K
Abbott$1K
Nevro Corp.$867
plus $1K from 13 others

$4,581in research payments, 2019–2025

Across 5 payments — averaging $916.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$5K

What the payments were for

Consulting fees$39,38824%
Speaking & faculty fees$102,21962%
Travel & lodging$9,9726%
Food & beverage$13,4028%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	351	$123,923
Medtronic(2 entities)	60	$18,411
Neuroone Medical Technologies Corporation	8	$17,608
Saluda Medical Americas, Inc.	17	$1,456
Abbott	32	$1,279
Nevro Corp.	23	$867
MML US, Inc.	6	$418
Relievant Medsystems, Inc.	8	$310
Pylant Medical	2	$173
Curonix LLC	1	$98
SPR Therapeutics, Inc	1	$97
Scilex Pharmaceuticals Inc.	5	$92
Pfizer	5	$69
Innovation Technologies Inc	2	$50
Nalu Medical, Inc.	2	$36
Averitas Pharma Inc.	1	$28
Bioventus LLC	1	$27
Zimmer Biomet	1	$24
Stimwave Technologies Incorporated	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL - THERAPIES$26,706
WaveWriter Alpha Prime 16$19,616
PRECISION$12,945
SPECTRA WAVEWRITER$9,213
INTELLIS$7,600
Intracept$5,608
INTELLIS ADAPTIVESTIM$5,240
Evoke SCS$982
RESTORE$638
GENERAL PAIN MANAGEMENT$423
PROCLAIM$375
ReActiv8$257
Evoke$153
Senza Spinal Cord Stimulation System$139
Senza$128

How this compares

$164,980 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$238,686

Medicare patients

704

Services billed

3,751

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	427	$11,857
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	50	$1,583
Morphine Sulfate ErMorphine Sulfate	46	$1,311
Gabapentin	40	$657
Tramadol Hcl	70	$546
Oxycodone Hcl	22	$429
Pregabalin	29	$428
Acetaminophen-CodeineAcetaminophen With Codeine	24	$398
Topiramate	30	$230
Tizanidine Hcl	28	$201
Methocarbamol	12	$190
Duloxetine Hcl	11	$189
Prednisone	12	$20

Paid to pharmacies, not to this prescriber.

Other pain medicine in Rockwall

Melissa MurphyGrapevine$653K
Shiraz YazdaniLubbock$514K
Aaron CalodneyTyler$296K
Candice BurnetteSugar Land$265K
Ashley Bailey-ClassenFort Worth$244K
Grant ChenHouston$175K
Gunjan PatelHouston$166K
Puneet SayalCorpus Christi$153K
Eduardo GarciaWebster$147K
Jaideep MehtaHouston$134K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →